Repro Med Systems (KRMD) Tops Q1 EPS by 2c

Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $11.23 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• OpenAI's Altman: rise in cost of compute and memory definitely a headwind - CNBC Interview
• UBS Reiterates Neutral Rating on CMS Energy (CMS) as Weak Q2 Earnings Expected
• Bernstein: 'Case studies from Microchip and other Semiconductor LTAs - What's different this time?'